{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:05:08Z","timestamp":1790690708251,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmr.2026.09.006","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:18:49Z","timestamp":1790687929000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quelle place pour les cortico\u00efdes dans le traitement de la pneumonie communautaire\u00a0?"],"prefix":"10.1016","author":[{"given":"P.-F.","family":"Dequin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2026.09.006_bib0240","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288\u00a0causes of death and life expectancy decomposition in 204\u00a0countries and territories and 811\u00a0subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2026.09.006_bib0245","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMcp2303286","article-title":"Community-acquired pneumonia","volume":"289","author":"File","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0250","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thx.2008.109785","article-title":"New perspectives on community-acquired pneumonia in 388,406\u00a0patients. Results from a nationwide mandatory performance measurement programme in healthcare quality","volume":"64","author":"Ewig","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2026.09.006_bib0255","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0260","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/resp.13112","article-title":"Pneumonia in the developing world: characteristic features and approach to management","volume":"22","author":"Aston","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.rmr.2026.09.006_bib0265","doi-asserted-by":"crossref","first-page":"1702215","DOI":"10.1183\/13993003.02215-2017","article-title":"Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia","author":"Cilloniz","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2026.09.006_bib0270","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.chest.2020.03.051","article-title":"The burden of community-acquired pneumonia requiring admission to ICU in the United States","volume":"158","author":"Cavallazzi","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2026.09.006_bib0275","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.chest.2018.05.021","article-title":"In-hospital deaths among adults with community-acquired pneumonia","volume":"154","author":"Waterer","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2026.09.006_bib0280","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jinf.2016.01.002","article-title":"Biomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and meta-analysis","volume":"72","author":"Viasus","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.rmr.2026.09.006_bib0285","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2024.14796","article-title":"Community-acquired pneumonia: a review","volume":"332","author":"Vaughn","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2026.09.006_bib0290","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","article-title":"Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study","volume":"167","author":"Kellum","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0295","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1183\/09031936.00040710","article-title":"Factors associated with inflammatory cytokine patterns in community-acquired pneumonia","volume":"37","author":"Mart\u00ednez","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2026.09.006_bib0300","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2119\/molmed.2009.00091","article-title":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia","volume":"15","author":"Milbrandt","year":"2009","journal-title":"Mol Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0305","doi-asserted-by":"crossref","first-page":"e22847","DOI":"10.1371\/journal.pone.0022847","article-title":"Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths","volume":"6","author":"Yende","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2026.09.006_bib0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","volume":"44","author":"Czock","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rmr.2026.09.006_bib0315","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.rmr.2026.09.006_bib0320","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/pr.119.018101","article-title":"Transitioning from basic toward systems pharmacodynamic models: lessons from corticosteroids","volume":"72","author":"Ayyar","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.rmr.2026.09.006_bib0325","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1007\/s00134-020-06289-8","article-title":"Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS","volume":"46","author":"Meduri","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0330","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00134-025-07912-2","article-title":"Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis","volume":"51","author":"Pitre","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0335","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/ANNALS-25-03055","article-title":"Systemic corticosteroids, mortality, and infections in pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"179","author":"Soumare","year":"2026","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0340","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/a-2704-6851","article-title":"Glucocorticoid treatment in community-acquired-pneumonia","volume":"47","author":"Dequin","year":"2026","journal-title":"Semin Resp Crit Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0345","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2507100","article-title":"A pragmatic trial of glucocorticoids for community-acquired pneumonia","volume":"393","author":"Lucinde","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0350","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2026.09.006_bib0355","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2026.09.006_bib0360","doi-asserted-by":"crossref","first-page":"2002535","DOI":"10.1183\/13993003.02535-2020","article-title":"Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial","volume":"58","author":"Wittermans","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2026.09.006_bib0365","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1183\/13993003.00474-2016","article-title":"Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia","volume":"48","author":"Wirz","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2026.09.006_bib0370","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2026.09.006_bib0375","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia","volume":"48","author":"Meduri","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0380","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0385","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00134-025-07861-w","article-title":"Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. The REMAP-CAP corticosteroid domain randomized clinical trial","volume":"51","author":"Angus","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0390","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0395","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S.\u00a0adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0400","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024\u00a0focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0405","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for Covid-19","volume":"370","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2026.09.006_bib0410","first-page":"CD010406","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza","volume":"2","author":"Lansbury","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2026.09.006_bib0415","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1038\/s41598-020-59732-7","article-title":"Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis","volume":"10","author":"Zhou","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.rmr.2026.09.006_bib0420","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0425","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00134-026-08387-5","article-title":"Corticosteroids for severe influenza pneumonia: a persistent evidence gap. Author's reply","volume":"52","author":"Dequin","year":"2026","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0430","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"323","author":"Bozzette","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0435","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S2213-2600(25)00125-0","article-title":"Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial","volume":"13","author":"Lemiale","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0440","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.rmr.2025.01.003","volume":"42","author":"Dinh","year":"2025","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2026.09.006_bib0445","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00134-026-08361-1","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026","volume":"52","author":"Prescott","year":"2026","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0450","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300034","article-title":"Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock","volume":"2","author":"Pirracchio","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.rmr.2026.09.006_bib0455","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","article-title":"Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3\u00a0randomised trial","volume":"12","author":"Heming","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0460","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00134-025-07873-6","article-title":"Sepsis subphenotypes, theragnostics and personalized sepsis care","volume":"51","author":"Antcliffe","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0465","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-2600(24)00405-3","article-title":"Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials","volume":"13","author":"Smit","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2026.09.006_bib0470","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2213-2600(25)00429-1","article-title":"Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trial","volume":"14","author":"Michels","year":"2026","journal-title":"Lancet Respir Med"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842526000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842526000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:18:55Z","timestamp":1790687935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842526000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S0761842526000604"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2026.09.006","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quelle place pour les cortico\u00efdes dans le traitement de la pneumonie communautaire\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2026.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS on behalf of SPLF.","name":"copyright","label":"Copyright"}]}}